Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival (Q45287934)
Jump to navigation
Jump to search
scientific article published on 28 February 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival |
scientific article published on 28 February 2005 |
Statements
1 reference
Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival (English)
1 reference
1 reference
Paul Moreton
1 reference
Ben Kennedy
1 reference
Guy Lucas
1 reference
Michael Leach
1 reference
Saad M B Rassam
1 reference
Andrew Haynes
1 reference
Jane Tighe
1 reference
David Oscier
1 reference
Christopher Fegan
1 reference
28 February 2005
1 reference
1 reference
23
1 reference
13
1 reference
2971-2979
1 reference
Identifiers
1 reference
1 reference